Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
B0P2TF
|
|||
| Binder Name |
Dazmegrel
|
|||
| Synonyms |
UNII-31340R8PVU; UK-38485; UK-38,485; 3-(Imidazol-1-ylmethyl)-2-methylindole-1-propionic acid; CHEMBL283656; 31340R8PVU; NCGC00160660-01; DSSTox_CID_26281; DSSTox_RID_81507; DSSTox_GSID_46281; Dazmegrelum [Latin]; Dazmegrelum; UK 38,485; Dazmegrel [USAN:INN:BAN]; Dazmegrel (USAN/INN); 1H-Indole-1-propanoic acid, 3-(1H-imidazol-1-ylmethyl)-2-methyl-; Oprea1_040141; CBDivE_000516; SCHEMBL154037; DTXSID9046281; CTK2H7526; 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-Indole-1-propanoic acid; Tox21_111966; BDBM50000317; CCG-20521; STK094650; ZINC35877948; AKOS005395464; Tox21_111966_1; MCULE-1200400346; NCGC00160660-02; DA-02947; EU-0045204; FT-0746556; ST50898364; D03661; SR-01000082437; SR-01000082437-1; Q27256003; 3-[3-(imidazolylmethyl)-2-methylindolyl]propanoic acid; 3-(3-Imidazol-1-ylmethyl-2-methyl-indol-1-yl)-propionic acid; 1H-Indole-1-propanoicacid, 3-(1H-imidazol-1-ylmethyl)-2-methyl-; 3-[3-(1H-imidazol-3-ium-3-ylmethyl)-2-methylindol-1-yl]propanoate; 3-[3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indol-1-yl]propanoic acid
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17N3O2
|
|||
| Canonical SMILES |
CC1=C(C2=CC=CC=C2N1CCC(=O)O)CN3C=CN=C3
|
|||
| InChI |
1S/C16H17N3O2/c1-12-14(10-18-9-7-17-11-18)13-4-2-3-5-15(13)19(12)8-6-16(20)21/h2-5,7,9,11H,6,8,10H2,1H3,(H,20,21)
|
|||
| InChIKey |
DEQLGSOHGTZKFB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.